BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11585770)

  • 21. Sequential expression of inducible nitric oxide synthase and cyclooxygenase-2 during DMBA-induced hamster buccal pouch carcinogenesis.
    Kim SA; Ahn SG; Kim DK; Kim SG; Lee SH; Kim J; Yoon JH
    In Vivo; 2004; 18(5):609-14. PubMed ID: 15523901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.
    Sakamoto A; Yokoyama Y; Umemoto M; Futagami M; Sakamoto T; Bing X; Mizunuma H
    Br J Cancer; 2004 Aug; 91(4):633-8. PubMed ID: 15266333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.
    Marrogi A; Pass HI; Khan M; Metheny-Barlow LJ; Harris CC; Gerwin BI
    Cancer Res; 2000 Jul; 60(14):3696-700. PubMed ID: 10919635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
    Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
    Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
    Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
    J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells.
    Narayanan BA; Narayanan NK; Simi B; Reddy BS
    Cancer Res; 2003 Mar; 63(5):972-9. PubMed ID: 12615711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human ovarian tumors express gamma-glutamyl transpeptidase.
    Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
    Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear localization of phosphorylated ERK1 and ERK2 as markers for the progression of ovarian cancer.
    Amsterdam A; Shezen E; Raanan C; Schreiber L; Prus D; Slilat Y; Ben-Arie A; Seger R
    Int J Oncol; 2011 Sep; 39(3):649-56. PubMed ID: 21687944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells.
    Shio MT; Ribeiro-Dias F; Timenetsky J; Jancar S
    Exp Cell Res; 2004 Aug; 298(1):296-304. PubMed ID: 15242784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide.
    Oh GS; Pae HO; Choi BM; Seo EA; Kim DH; Shin MK; Kim JD; Kim JB; Chung HT
    Cancer Lett; 2004 Mar; 205(1):23-9. PubMed ID: 15036657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
    Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
    Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages.
    Suh N; Honda T; Finlay HJ; Barchowsky A; Williams C; Benoit NE; Xie QW; Nathan C; Gribble GW; Sporn MB
    Cancer Res; 1998 Feb; 58(4):717-23. PubMed ID: 9485026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
    Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
    Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
    Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
    Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
    Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer.
    Bing RJ; Miyataka M; Rich KA; Hanson N; Wang X; Slosser HD; Shi SR
    Clin Cancer Res; 2001 Nov; 7(11):3385-92. PubMed ID: 11705852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer.
    Franco L; Doria D; Bertazzoni E; Benini A; Bassi C
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):51-8. PubMed ID: 15165031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure.
    Hukkanen M; Corbett SA; Batten J; Konttinen YT; McCarthy ID; Maclouf J; Santavirta S; Hughes SP; Polak JM
    J Bone Joint Surg Br; 1997 May; 79(3):467-74. PubMed ID: 9180331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.